key: cord-0052585-kept8luo
authors: Haftom, Mekonnen; Petrucka, Pammla; Gemechu, Kbrom; Nesro, Jemila; Amare, Embay; Hailu, Tsegu; Ashebir, Yohannes; Gebreheat, Gdiom; Hagos, Haftea; Gebremedhin, Destaalem; Gebremariam, Alem
title: Prevalence and Risk Factors of Human Leishmaniasis in Ethiopia: A Systematic Review and Meta-Analysis
date: 2020-11-10
journal: Infect Dis Ther
DOI: 10.1007/s40121-020-00361-y
sha: 61f020c179569c60d85a6939ff01c624116943e2
doc_id: 52585
cord_uid: kept8luo

INTRODUCTION: Tropical diseases are public health problems affecting hundreds of millions of people globally. However, the development of adequate, affordable, and accessible treatments is mostly neglected, resulting in significant morbidity and mortality that could otherwise be averted. Leishmaniasis is one of the neglected tropical diseases caused by the obligate intracellular protozoan Leishmania parasite and transmitted by the bite of infected phlebotomine sandflies. No systematic review and meta-analysis has been done to identify the prevalence and risk factors of leishmaniasis to the authors’ knowledge. Therefore, the objective was to determine the prevalence and risk factors of human leishmaniasis in Ethiopia. METHODS: Eleven studies conducted in all regions of Ethiopia, which were fully accessible, written in any language, and original articles done on prevalence and risk factors of leishmaniasis, were included. STATA™ version 11.1 was used for statistical analysis. Chi-square, I(2), and p values were assessed to check heterogeneity. A random effects model with heterogeneity taken from an inverse-variance model was employed to estimate the pooled effect. Subgroup meta-analysis was computed to reduce random variations among each article’s point prevalence, and Egger and funnel plots were used to check for publication bias. RESULTS: The highest proportion of human leishmaniasis was reported from a study done in Amhara region (39.1%), and the lowest was reported from a survey done in Tigray (2.3%). The overall pooled prevalence of leishmaniasis was 9.13% (95% CI 5–13.27). Subgroup analysis by region revealed moderate heterogeneity (I(2) = 51.8%) in studies conducted in the Southern Nations Nationalities and Peoples Region (SNNPR). The presence of hyraxes and being male were associated with an increased risk of human leishmaniasis. CONCLUSION: The prevalence of leishmaniasis in Ethiopia remains high (9.13%), with significant risk factors being male and the presence of hyraxes within a 300-m radius of the sleeping area.

Leishmaniasis impacts public health, socioeconomics, and the nation's economy and growth. There is lack of systematic review and meta-analysis on prevalence and risk factors of human leishmaniasis at country level. This direction further indicated a need to assess the prevalence and risk factors of human leishmaniasis.

Such a gap in knowledge further complicates the full understanding and evidentiary base needed to combat this disease. Therefore, this study determined the pooled prevalence and risk factors of human leishmaniasis in Ethiopia.

The prevalence of leishmaniasis remains high in Ethiopia (9.13%), and gender (male) and the presence of hyraxes within a 300-m radius of the sleeping area were significant risk factors. Vaccine development, methods of diagnosis, and treatment that can be affordable for developing countries should be given priority.

Globally, an estimated of 58,000 new cases of visceral leishmaniasis and 220,000 new cases of cutaneous leishmaniasis occur every year [1] . Nearly 40 million people are suffering from stigma due to inactive cutaneous leishmaniasis scars [2] . Neglected tropical diseases are a significant public health problem in Ethiopia, which is experiencing a considerable burden compared to other sub-Saharan African countries [3] . Leishmaniasis affects both humans and animals [4, 5] . The prevalence of animal leishmaniasis in Ethiopia was 11% (95% CI 5-16%) [6] . Neglected tropical diseases resulted in 3593 deaths in 2015 in Ethiopia [7] . Within Ethiopia, there are many neglected tropical diseases that result in the loss of quality of life and loss of lives. One such disease, leishmaniasis, a protozoan disease, is caused by over 20 different Leishmania spp., which are transmitted by female phlebotomine sandflies to humans [8] . The presentation of leishmaniasis can be subclinical, localized, or disseminated with its symptomatic stage manifesting as either acute or chronic [9] . There are three major types of the disease: visceral, cutaneous, and mucocutaneous [10] , with consequences ranging from skin lesions to death [11] . East Africa is the second-largest visceral leishmaniasis focus after the Indian subcontinent. East Africa contributes 30,000-40,000 new cases per year to the global burden, with the largest proportion of new leishmaniasis cases occurring in Ethiopia, South Sudan, and Sudan [12, 13] . Visceral leishmaniasis is characterized by anemia, prolonged fever, weight loss, and hepatosplenomegaly. If left untreated, it is fatal in 95% of cases [14, 15] .

Globally, tropical diseases affect hundreds of millions and place even more at risk [8, 16] . The World Health Organization/Tropical Disease Research (WHO/TDR) program focuses on the development of new diagnostics, vaccines, and drugs to combat these complex conditions. However, tropical diseases are globally dispersed, making it difficult for the treatment to be available and affordable for those most in need, who are often socioeconomically and politically marginalized. Furthermore, drug development is mostly neglected because of the relatively small populations affected, coupled with users' inability to pay for such drugs [16, 17] .

Leishmaniasis impacts public health, socioeconomics, and the nation's economy and growth [18] . Leishmaniasis causes high mortality, morbidity, affects the quality of life, causes mental illness, stigma, and psychosocial morbidity among those affected [17, 19] . Assefa did a systematic review and meta-analysis on leishmaniasis [6] . But it was focused on the prevalence of leishmaniasis among humans and animals. This direction further indicated a need to assess the prevalence and risk factors of human leishmaniasis as there is a lack of systematic review and meta-analysis on prevalence and risk factors of human leishmaniasis at the country level [1] . Such a gap in knowledge further complicates the full understanding and evidentiary base needed to combat this disease. Therefore, this study determined the pooled prevalence and risk factors of human leishmaniasis in Ethiopia.

This systematic review and meta-analysis considered original studies, including cross-sectional and retrospective cohort studies, conducted in all Ethiopian regions on prevalence and factors associated with leishmaniasis. This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.

Fully accessible (either through online, library, or author access at no cost) published articles concerned with leishmaniasis prevalence and risk factors, peer-reviewed, published in any language, and including Ethiopian populations.

We excluded systematic reviews, meta-analysis, commentaries, case-control (denominators are already predetermined), case series, case reports, studies done in animals, and inaccessible articles (unable to contact the primary author after three attempts to retrieve the full text of the papers). Following the Preferred Reporting Item for Systematic Review and Meta-analysis (PRISMA) guidelines [20] , a comprehensive computer search in PubMed, Google Scholar, Cochrane Library, Science Direct, African Journals Online, and JURN on prevalence and risk factors of leishmaniasis was performed. The search was done with geographical location restricted to Ethiopia. Related articles and references were identified from some included articles and were also searched. Boolean operators (''OR'' or ''AND'') were used in combination or separately to search the terms. Peer-reviewed articles published from November 1993 until December 2019, which were fully accessible, were included. Medical Subject Headings (MeSH) terms (((magnitude) OR leishmaniasis) OR associated factors) OR Ethiopia, (((prevalence) OR leishmaniasis) OR risk factors) OR Ethiopia) were initially used. The last search was done using (((prevalence) AND leishmaniasis) AND risk factors) AND Ethiopia.

Three individuals (MH, KG, and JN) searched the electronic databases using similar MeSH terms to identify possible eligible articles on the basis of the title and abstracts imported to Endnote version 7 (Thomson Reuters, NY, USA). Duplicate reports were removed. Title and abstract reviews were performed. Articles with adequate data concerning the inclusion criteria were saved for full-text assessment. The Newcastle-Ottawa Scale [21] adapted for cross-sectional study quality assessment was used to assess the quality of each article. Each article was scored by three reviewers independently. In the event of disagreements, the reviewers reached a consensus or voted to determine the disposition of the article. Articles with a quality assessment score of greater than 6/10 were considered high quality and were included in this review.

Three individual reviewers (MH, KG, and JN) independently conducted the data extraction using a standardized data extraction checklist. The checklist included the name of the first author, prevalence, standard error, type of test, year of publication, a region of the study, study setting, study population, gender of participants, age, study design, sample size, type of leishmaniasis, and other variables. If authors disagreed on whether to include or exclude an article, a majority decision was made ( Fig. 1 ).

STATA TM version 11.1 statistical software was used for analysis. The standard error for each original study was calculated using the binomial distribution formula. Chi-square, I 2 , and p values were assessed to check heterogeneity. Though the pooled I 2 shows no heterogeneity, we queried differences in assumptions amongst the individual studies. Therefore, a random effects model with heterogeneity taken from an inverse-variance model (DerSimonian and Laird, 1986) was employed to estimate the pooled effect. Subgroup metaanalysis was computed on the basis of the type of study design, the region where the research was conducted, and the type of leishmaniasis to reduce random variations among the point prevalence of each article. Egger and funnel plot tests were done to check for publication bias. First author, year of publication, point prevalence, and 95% confidence interval were presented using forest plots. Each identified potential determinant factor was checked regarding the effect on the prevalence of human leishmaniasis. The size of each box on the forest plot indicates the weight of each article, and the cross lines refer to a 95% confidence interval.

The years of publication of included articles ranged from November 1993 to September 2019. Of the total articles that fulfilled the eligibility criteria, 11 were selected for systematic review and meta-analysis, ten of which were community-based. The total sample size included from all the eligible articles was 50,883. Over one-third (36.36%) of the studies were conducted in the Tigray region. The highest proportion of leishmaniasis was reported from a study done in Amhara region (39.1%), followed by SNNPR (36.4%), and the lowest prevalence was reported from a study done in Tigray region (2.3%) [22] [23] [24] (Table 1) . Of the 11 studies, nine studies were cross-sectional [22, [24] [25] [26] [27] [28] [29] [30] [31] , and the rest [23, 32] were retrospective studies. Included studies were done in five of the nine regions of the country. Although the value of I 2 = 0.0%, differences in the assumptions of individual articles were expected; hence, a random effects model was employed using sample size and positive participants to determine the countrylevel pooled prevalence. The overall pooled prevalence of leishmaniasis was 9.13% (95% CI 5-13.27) with heterogeneity chi-squared = 6.83, p = 0.741, df = 10, and I 2 = 0.0% (Fig. 2) .

Subgroup meta-analysis was done on the basis of the region of the study, the type of leishmaniasis, and type of study design employed. Subgroup analysis by region (SNNPR, Tigray, Amhara, Somali, and Benshangul Gumuz) revealed moderate heterogeneity (I 2 = 51.8%) in studies conducted in SNNPR. No heterogeneity was observed regarding study designs, and subtotal random proportion of the study designs showed that 9.13% (95% CI 4.91-13.21) was attributable to cross-sectional study design (Table 2) . Regarding the type of leishmaniasis, the pooling subtotal under a random effects model implies that 9.44% (95% CI 5.1-13.78) of the type of leishmaniasis was visceral (kalaazar), and the subtotal prevalence for cutaneous leishmaniasis was 6.03% (95% CI 7.83-19.9) (Fig. 3 ).

A total of 23 variables (Table 3) were examined in this review for their effect on human leishmaniasis prevalence. Thirteen of the variables (i.e., the residence of daily laborers, knowledge about the mode of transmission, dog ownership, educational status, presence of termite mounds, presence of bed nets, resettlement status, the residence of participants, sleeping under a Ballantine tree, type of house, season, origin, and presence of cave within a 300-m radius) were mentioned in single articles as risk factors. Therefore, the pooled effect was not calculated for such variables. From the remaining ten variables tested for their effect on the prevalence of human leishmaniasis, the presence of hyraxes within a 300-m radius of sleep area and gender were significantly associated with the prevalence of human leishmaniasis in the final systematic review and metaanalysis. Pooling from two studies [24, 30] showed that the presence of hyraxes within a 300-m radius of the sleeping area was associated with the prevalence of human leishmaniasis (OR 2.96; 95% CI 1.67-5.245). Pooling from ten studies [22] [23] [24] [25] [26] [27] [28] [29] [30] 32] showed that female individuals were less likely to be affected by leishmaniasis compared to their male counterparts (OR 0.6; 95% CI 0.46-0.82). No other study variables showed an association with the prevalence of human leishmaniasis (Table 4) .

Egger and funnel plot tests were done to determine publication bias (Fig. 4) , yielding no evidence of bias with a p value of 0.19 (95% CI -0.356 to 1.548).

Infect Dis Ther

Despite the prevalence of neglected tropical diseases in Ethiopia, funding to control and investigate geographic distribution is limited [3] . Risk assessment at the country level is poor in Ethiopia and the non-specific symptoms of leishmaniasis have made it difficult to treat. Many of the available methods of diagnosis are not appropriate in Ethiopia [10] . Therefore, this study focused on prevalence and risk factors of human leishmaniasis at the country level. Human leishmaniasis was present, highly prevalent, and reported in more than half of the regions of the country. These findings are supported by previous studies suggesting that the Horn of Africa bears the largest burden of leishmaniasis with northern regions of Ethiopia around the borders of Sudan most affected [33, 34] . This pattern might reflect the unavailability of a vaccine, inadequate vector control, and insufficient access to new drugs [9] . Others suggest that this trend might be due to migration and conflict [34] ; lack of advancement in diagnostics and treatment of the disease; or unaffordability of the new advanced technologies (i.e., vaccine, treatment, and diagnostics) to eradicate leishmaniasis [35] .

Leishmaniasis was more prevalent in Amhara region followed by SNNPR, showing low reported prevalence in Tigray. Visceral leishmaniasis was the most prevalent type across all regions. This study showed that the risk of having leishmaniasis is increased among male individuals, which mirrors a previous study in Sudan [36] . This finding could potentially reflect that male individuals are more likely to be in agricultural fields and move during the night. This study showed that the presence of hyraxes within a 300-m radius of the sleeping area increased the risk of acquiring the disease. Previous studies revealed similar findings [12, 37] with an explanation that hyraxes are natural reservoirs of leishmaniasis [3] . In some studies, the presence of domestic animals around sleeping areas was ambiguous for risk factors for the prevalence of leishmaniasis [36, 38] , although this finding was less evident in another study [37] .

In contrast, the current study revealed that the presence of domestic animals does not affect the prevalence of leishmaniasis. This systematic review and meta-analysis showed that the remaining variables (Table 4 ) did not affect leishmaniasis prevalence. These findings are in disagreement with previous studies that suggest Hyraxes within 300-m radius sleeping outdoors [34, 36, 38] , age [36] , presence of a gorge within a 300-m radius of the sleeping area [24, 30] , presence of acacia [33, 36] , and travel history to leishmaniasis endemic areas [27] were significantly associated with human leishmaniasis.

The prevalence of leishmaniasis remains high in Ethiopia (9.13%), and gender (male) and the presence of hyraxes within a 300-m radius of the sleeping area were significant risk factors. Even though there is a reduction in the magnitude of leishmaniasis and there are advances in diagnosis and treatments [16, 17] , this disease remains challenging to assess and manage in developing countries like Ethiopia. Substantial gaps and inconsistencies were seen between the findings of the individual articles and systematic review and meta-analysis, clearly indicating the need for more intensive and national studies on this condition. Leishmaniasis was one of the WHO's targets for elimination and control by 2020. However, our findings highlight that leishmaniasis is still a prevalent and neglected disease, contributing its share to the global burden of neglected tropical diseases (NTD). Since the current medications are decades old and full of limitations [35] , new vaccines, methods of diagnosis, and treatment for its eradication should be given priority, and prophylaxes should also be considered to prevent relapse. Researchers around the world might also consider their investment in human leishmaniasis, especially in innovation for new treatments and diagnostics that can be affordable for developing countries. Epidemiological investigations of possible risk factors for human leishmaniasis, clinical trials for evidence-based practices, investigations of treatment failure, and investigation on the geographical distribution of hyraxes are recommended. Mass screening and follow-ups of interventions are also recommended. and preparation of the manuscript.

Funding. No funding or sponsorship was received for this study or publication of this article.

Authorship. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Authorship Contributions. MH idea conception, proposal preparation, data analysis, wrote the paper, presented the paper, and drafted the manuscript. PP, KG, JN, EA, TH, YA, GG, HH, DG, and AG cooperated in the development of the proposal, presentation of the proposal, and data analysis and critically reviewed the manuscript. All authors accepted the final manuscript and took part in the evaluation and review of the manuscript.

Disclosures. Mekonnen Haftom, Pammla Petrucka, Kbrom Gemechu, Jemila Nesro, Embay Amare, Tsegu Hailu, Yohannes Ashebir, Gdiom Gebreheat, Haftea Hagos, Destaalem Gebremedhin and Alem Gebremariam declare that they have no competing interests.

Compliance with Ethics Guideline. This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.

Data Availability. The datasets used and analyzed during this study are available from the corresponding author on reasonable request.

Open Access. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/bync/4.0/.

Leishmaniasis worldwide and global estimates of its incidence

A new perspective on cutaneous leishmaniasis-implications for global prevalence and burden of disease estimates

The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination

One Health: the global challenge of epidemic and endemic leishmaniasis

Transmission and epidemiology of zoonotic protozoal diseases of companion animals

Leishmaniasis in Ethiopia: a systematic review and meta-analysis of prevalence in animals and humans. Heliyon

Mortality and disability-adjusted life-years (dalys) for common neglected tropical diseases in Ethiopia, 1990-2015: evidence from the global burden of disease study 2015

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Advances in leishmaniasis

Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa

Leishmaniasis impact and treatment access

Control of neglected tropical diseases

Identification of environmental parameters and risk mapping of visceral leishmaniasis in Ethiopia by using geographical information systems and a statistical approach

Visceral leishmaniasis in Aba-Roba, south-western Ethiopia: prevalence and incidence of active and subclinical infections

Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan

Drug discovery and development for neglected parasitic diseases

Drug development for neglected diseases: a deficient market and a public-health policy failure

Eco-epidemiology of visceral leishmaniasis in Ethiopia

The impact of leishmaniasis on mental health and psychosocial well-being: a systematic review

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis

Visceral leishmaniasis in Ethiopia. I. Cross-sectional leishmanin skin test in an endemic locality

Trend analysis of visceral leishmaniasis at Addis Zemen health center

Prevalence and environmental determinants of cutaneous leishmaniasis in rural communities in Tigray, northern Ethiopia

Visceral leishmaniasis in Benishangul-Gumuz regional state, Western Ethiopia: reemerging or emerging?

Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia

Seroprevalence of asymptomatic leishmania donovani Infect Dis Ther among laborers and associated risk factors in agricultural camps of West Armachiho District, Northwest Ethiopia: a cross-sectional study

Visceral leishmaniasis in selected communities of Hamar and Banna-Tsamai districts in Lower Omo Valley

Serological investigation of visceral Leishmania infection in human and its associated risk factors in Welkait District

Epidemiological study of cutaneous leishmaniasis in Saesie Tsaedaemba district, eastern Tigray, northern Ethiopia

Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification

Incidence and trends of leishmaniasis and its risk factors in Humera, Western Tigray

Risk factors for visceral leishmaniasis among residents and migrants in Kafta-Humera, Ethiopia

Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden

Treatment of cutaneous leishmaniasis caused by Leishmania aethiopica: a systematic review

Determinants of visceral leishmaniasis: a case-control study in Gedaref State, Sudan

Cutaneous leishmaniasis due to leishmania aethiopica

Risk factors of visceral leishmaniasis: a case control study in north-western Ethiopia

The authors thank Adigrat University and Berhane Fisha for coordinating and supporting the development